BIOMAT Database Logo BIOMAT Database Logo

[Use of highly sensitive methods of detecting hepatitis B virus markers for studying epidemic foci of hepatitis B]. 1985

S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev

Passive hemagglutination test (PHA) was found to detect HBsAg in the population living outside the hepatitis B virus foci 1.5-fold as frequently as counter immunoelectroosmophoresis technique, and anti-HBs by enzyme immunoassay 14-fold as frequently. As compared with normal population, the contacts in foci had 4-fold higher levels of HBsAg carrier state and twice as high rates of detection of anti-HBs. The total index of HBV infection in foci was 27.7%. The above materials considerably extend the concepts of HBV epidemiology. The regularity of the results obtained indicate the specificity and high sensitivity of PHA and EIA tests and suggests that they be used on a wider scale.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008297 Male Males
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003378 Counterimmunoelectrophoresis Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow. Electrosyneresis,Immunoelectroosmophoresis,Immunoelectrophoresis, Countercurrent,Immunoelectrophoresis, Crossover,Countercurrent Immunoelectrophoresis,Crossover Immunoelectrophoresis
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004197 Disease Reservoirs Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks. Humans may serve both as disease reservoirs and carriers. Disease Reservoir,Human Disease Reservoirs,Infectious Disease Reservoir,Reservoirs of Infection,Infectious Disease Reservoirs,Disease Reservoir, Human,Disease Reservoir, Infectious,Disease Reservoirs, Human,Human Disease Reservoir,Infection Reservoir,Infection Reservoirs,Reservoir, Disease,Reservoir, Infectious Disease,Reservoirs, Human Disease
D005260 Female Females
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination

Related Publications

S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Use of a highly-sensitive method of electrophoresis-precipitation for detecting hepatitis B virus antigen in human serum].
April 1977, Biulleten' eksperimental'noi biologii i meditsiny,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Highly sensitive variant of the passive hemagglutination reaction for detecting hepatitis B virus surface antigens].
January 1985, Laboratornoe delo,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.
August 2013, Clinical and vaccine immunology : CVI,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[A highly sensitive method of detecting the structural proteins of hepatitis A virus].
January 1990, Laboratornoe delo,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Hepatitis B virus markers].
February 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Viral infection markers in foci of chronic hepatitis B].
January 1988, Voprosy virusologii,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Performance evaluation of the IS1200 domestic chemiluminescence analyzer for detecting hepatitis B virus serum markers].
May 2015, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
Radioimmunoassay and enzyme immunoassay methods for detecting viral hepatitis markers.
October 1983, American journal of clinical pathology,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
Isotachophoresis preconcentration integrated microfluidic chip for highly sensitive genotyping of the hepatitis B virus.
November 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
S L Mukomolov, and S A Arakelov, and L I Shliakhtenko, and V A Anan'ev, and V V Nechaev
[Highly sensitive methods for the serological,diagnosis of hepatitis B and their clinico-epidemiological significance].
January 1990, Terapevticheskii arkhiv,
Copied contents to your clipboard!